LABCORP EXPANDS DRUG DEVELOPMENT SOLUTIONS WITH ACQUISITION OF SCIFORMIX
Sciformix extends Covance’s pharmacovigilance capabilities for post-approval safety solutions Burlington, N.C.—June 11, 2018—LabCorp® (NYSE: LH), a leading global...
Read MorePress Releases
Sciformix Launches RightOutcomes, an Innovative, Analytics Based Real World Evidence Solution
Sciformix’s RightOutcomes Analytics Solution leverages domain expertise and a leading life sciences technology platform to enable better insights...
Read MoreSciformix Corporation Launches Safety and Risk Management Technology Platform
New Platform transforms and enhances safety and risk management services offerings to reduce complexity, achieve operational excellence, and...
Read MoreSciformix and Cambridge Semantics Partner to Create Enhanced Pharmacovigilance Automation and Technology Platform
New partnership enables safety organizations to greatly reduce timelines, increase quality, and glean enhanced insights for effective scientific...
Read MoreSciformix Collaborates with Oracle Health Sciences to Offer Validated Argus Drug Safety Solutions
New collaboration enables faster and more informed drug safety decisions Boston, MA. – November 06, 2017, – Sciformix...
Read More